Last week, FreeThink Technologies exhibited its new proprietary technology at the Controlled Release Society Annual Meeting and Expo in Montreal.
OzmoCAP® is an oral extended release osmotic capsule that provides a range of drug release durations controlled by the capsule, not the drug’s properties. The OzmoCAP® technical team can develop, produce, and ship filled capsules with client active ingredients of known release rates for animal testing in a matter of weeks, and is actively developing capabilities to provide materials for human clinical studies.
Contact us or visit How OzmoCAP® Works to learn more.
Photo caption: From left, Business Development Manager Dave Lucey and Technology Development Lead Dr. Jennifer Chu exhibit OzmoCAP® at this year’s CRS Expo.
From left, Business Development Manager Dave Lucey and Technology Development Lead Dr. Jennifer Chu exhibit OzmoCAP® at this year’s CRS Expo.